Data / Form D filings / ST RENATUS LLC
ST RENATUS LLC: Form D filings
ST RENATUS LLC, a pharmaceuticals company in Ft Collins, CO, filed 10 Form D notices with the SEC between 2009 and 2018. The latest, on June 22, 2018, reports an offering of $26 million with nothing sold yet.
Find out what ST RENATUS LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1000 CENTRE AVENUE, Ft Collins, CO, 80526
- Phone
- (970) 999-3537
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1433959
The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 22, 2018 | New notice | $26,000,000 | $0 | $26,000,000 | 0 | Yet to occur | sec.gov |
| Apr 27, 2017 | New notice | $9,000,000 | $1,060,000 | $7,940,000 | 6 | Apr 12, 2017 | sec.gov |
| Sep 3, 2014 | New notice | $2,080,000 | $65,000 | $2,015,000 | 1 | Aug 27, 2014 | sec.gov |
| Jan 7, 2014 | New notice | $2,500,000 | $66,300 | $2,433,700 | 3 | Dec 27, 2013 | sec.gov |
| Dec 14, 2012 | New notice | $5,000,000 | $100,000 | $4,900,000 | 1 | Dec 7, 2012 | sec.gov |
| Jun 20, 2012 | New notice | $2,400,000 | $40,000 | $2,360,000 | 1 | Jun 20, 2012 | sec.gov |
| Apr 4, 2012 | Amendment | $6,580,000 | $5,828,830 | $751,170 | 124 | Jun 9, 2011 | sec.gov |
| Jun 16, 2011 | New notice | $3,500,000 | $178,990 | $3,321,010 | 1 | Jun 9, 2011 | sec.gov |
| Nov 25, 2009 | New notice | $3,150,000 | $141,750 | $3,008,250 | 2 | Nov 16, 2009 | sec.gov |
| May 5, 2009 | New notice | $12,100,000 | $110,000 | $11,990,000 | 2 | Apr 22, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James L Parke | Director | |
| Stephen D Tebo | Director | |
| Brent M T Keele | Director | |
| Jerry M Morgensen | Director | |
| Joesph D Schofield III | Director | |
| Terence M Tucker | Executive Officer | |
| Frank R Ramirez | Executive Officer, Director |
Every Form D from the week of Jun 18, 2018 · All recent filings in Colorado · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ST RENATUS LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.